PGD2

Pgd2 is a lipid of Fatty Acyls (FA) class. Pgd2 is associated with abnormalities such as Inflammatory disorder, Pleurisy, Rhinitis, Dehydration and Pneumonia. The involved functions are known as antagonists, fat cell differentiation, Phosphorylation, Process and Gene Expression. Pgd2 often locates in Cell surface, Body tissue, Extracellular, Bone Marrow and Membrane. The associated genes with PGD2 are oxytocin, 1-desamino-(O-Et-Tyr)(2)-, P4HTM gene, PTGS2 gene, PTGDS gene and IL3 gene. The related lipids are 15-deoxyprostaglandin J2, Nonesterified Fatty Acids, Lipopolysaccharides, Steroids and Liposomes. The related experimental models are Knock-out and Rodent Model.

Cross Reference

Introduction

To understand associated biological information of PGD2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with PGD2?

PGD2 is suspected in Asthma, Dehydration, Allergic rhinitis NOS, Rhinitis, Infertility, Pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with PGD2

MeSH term MeSH ID Detail
Persistent Fetal Circulation Syndrome D010547 1 associated lipids
Zollinger-Ellison Syndrome D015043 1 associated lipids
Mastocytosis, Systemic D034721 1 associated lipids
Anal Gland Neoplasms D000694 1 associated lipids
Trigeminal Neuralgia D014277 1 associated lipids
Pulmonary Aspergillosis D055732 1 associated lipids
Cystitis, Interstitial D018856 2 associated lipids
Decapitation D049248 2 associated lipids
Asthma, Aspirin-Induced D055963 2 associated lipids
Optic Neuropathy, Ischemic D018917 2 associated lipids
Choroid Diseases D015862 2 associated lipids
Angioedemas, Hereditary D054179 2 associated lipids
Epilepsy, Tonic-Clonic D004830 2 associated lipids
Cryptorchidism D003456 2 associated lipids
HTLV-I Infections D015490 3 associated lipids
Respiratory Sounds D012135 3 associated lipids
Ascariasis D001196 3 associated lipids
Sleep Disorders, Circadian Rhythm D020178 3 associated lipids
Wounds, Stab D014951 3 associated lipids
Graves Ophthalmopathy D049970 3 associated lipids
Cryptococcosis D003453 3 associated lipids
Cholangitis D002761 3 associated lipids
Dirofilariasis D004184 3 associated lipids
Leukemia, B-Cell D015448 3 associated lipids
Airway Remodeling D056151 3 associated lipids
Nasal Obstruction D015508 4 associated lipids
Idiopathic Pulmonary Fibrosis D054990 4 associated lipids
Goiter D006042 4 associated lipids
Headache D006261 4 associated lipids
Actinobacillus Infections D000189 4 associated lipids
Urticaria Pigmentosa D014582 4 associated lipids
Meningoencephalitis D008590 4 associated lipids
Coronavirus Infections D018352 4 associated lipids
Muscular Dystrophy, Animal D009137 5 associated lipids
Vasculitis, Leukocytoclastic, Cutaneous D018366 5 associated lipids
Hematoma D006406 5 associated lipids
Myeloproliferative Disorders D009196 5 associated lipids
Leukodystrophy, Globoid Cell D007965 6 associated lipids
Fetal Alcohol Spectrum Disorders D063647 6 associated lipids
Xeroderma Pigmentosum D014983 6 associated lipids
Sneezing D012912 6 associated lipids
Hyperlipoproteinemia Type IV D006953 6 associated lipids
Tauopathies D024801 6 associated lipids
Rhinitis, Allergic, Perennial D012221 6 associated lipids
Thrombophilia D019851 6 associated lipids
Brain Damage, Chronic D001925 6 associated lipids
Sleep Wake Disorders D012893 7 associated lipids
Plaque, Atherosclerotic D058226 7 associated lipids
Cholangiocarcinoma D018281 7 associated lipids
Rhinitis, Allergic, Seasonal D006255 7 associated lipids
Per page 10 20 50 100 | Total 189

PubChem Associated disorders and diseases

What pathways are associated with PGD2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with PGD2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with PGD2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with PGD2?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with PGD2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with PGD2?

Knock-out

Knock-out are used in the study 'Multiple roles of the prostaglandin D2 signaling pathway in reproduction.' (Rossitto M et al., 2015).

Rodent Model

Rodent Model are used in the study 'PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation.' (Kong D et al., 2016).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with PGD2

Download all related citations
Per page 10 20 50 100 | Total 3138
Authors Title Published Journal PubMed Link
Murphy PJ et al. Nonsteroidal anti-inflammatory drugs affect normal sleep patterns in humans. 1994 Physiol. Behav. pmid:8047572
Kim SY et al. Effects of tanshinone I isolated from Salvia miltiorrhiza bunge on arachidonic acid metabolism and in vivo inflammatory responses. 2002 Phytother Res pmid:12410540
Choi HG et al. Inhibition of prostaglandin Dâ‚‚ production by trihydroxy fatty acids isolated from Ulmus davidiana var. japonica. 2013 Phytother Res pmid:23147809
Tomita Y et al. Melanocyte-stimulating properties of arachidonic acid metabolites: possible role in postinflammatory pigmentation. 1992 Pigment Cell Res. pmid:1292020
Lappas M et al. Effect of nuclear factor-kappa B inhibitors and peroxisome proliferator-activated receptor-gamma ligands on PTHrP release from human fetal membranes. 2004 Sep-Oct Placenta pmid:15450387
Keelan JA et al. Cytokines, prostaglandins and parturition--a review. 2003 Placenta pmid:12842412
Suwaki N et al. Expression and potential role of peroxisome proliferator-activated receptor gamma in the placenta of diabetic pregnancy. 2007 Placenta pmid:16753211
Marvin KW et al. The 15-deoxy-delta(12,14)-prostaglandin J(2)receptor, peroxisome proliferator activated receptor-gamma (PPARgamma) is expressed in human gestational tissues and is functionally active in JEG3 choriocarcinoma cells. 2000 Placenta pmid:10833383
Lundin-Schiller S and Mitchell MD Prostaglandin production by human chorion laeve cells in response to inflammatory mediators. 1991 Jul-Aug Placenta pmid:1946245
Fournier T et al. Involvement of PPARgamma in human trophoblast invasion. 2007 Placenta pmid:17321592
Moore RM et al. Physiological apoptotic agents have different effects upon human amnion epithelial and mesenchymal cells. 2003 Feb-Mar Placenta pmid:12566244
Lappas M et al. 15-Deoxy-Delta(12,14)-prostaglandin J(2) and troglitazone regulation of the release of phospholipid metabolites, inflammatory cytokines and proteases from human gestational tissues. 2006 Nov-Dec Placenta pmid:16434095
Hölscher C et al. Defects in Peroxisomal 6-Phosphogluconate Dehydrogenase Isoform PGD2 Prevent Gametophytic Interaction in Arabidopsis thaliana. 2016 Plant Physiol. pmid:26941195
Baolin L et al. Resveratrol inhibits the release of mediators from bone marrow-derived mouse mast cells in vitro. 2004 Planta Med. pmid:15095144
Mondoro TH and Vostal JG Cold temperatures reduce the sensitivity of stored platelets to disaggregating agents. 2002 Platelets pmid:11918832
Pataki I et al. In vivo effects of isatin on rat platelet eicosanoids. 2005 Platelets pmid:15763895
Yang G et al. Systemic PPARγ deletion impairs circadian rhythms of behavior and metabolism. 2012 PLoS ONE pmid:22899986
Lefils-Lacourtablaise J et al. The eicosapentaenoic acid metabolite 15-deoxy-δ(12,14)-prostaglandin J3 increases adiponectin secretion by adipocytes partly via a PPARγ-dependent mechanism. 2013 PLoS ONE pmid:23734181
Benedetti F and Dogue S Different Placebos, Different Mechanisms, Different Outcomes: Lessons for Clinical Trials. 2015 PLoS ONE pmid:26536471
Wappler EA et al. Mitochondrial dynamics associated with oxygen-glucose deprivation in rat primary neuronal cultures. 2013 PLoS ONE pmid:23658809
Nicholson JD et al. PGJ(2) provides prolonged CNS stroke protection by reducing white matter edema. 2012 PLoS ONE pmid:23284631
Templeton DJ et al. Purification of reversibly oxidized proteins (PROP) reveals a redox switch controlling p38 MAP kinase activity. 2010 PLoS ONE pmid:21085594
Xiao L et al. Lipopolysaccharide-induced expression of microsomal prostaglandin E synthase-1 mediates late-phase PGE2 production in bone marrow derived macrophages. 2012 PLoS ONE pmid:23226252
Sykes L et al. Chemoattractant receptor homologous to the T helper 2 cell (CRTH2) is not expressed in human amniocytes and myocytes. 2012 PLoS ONE pmid:23226366
Wang P et al. Interleukin-6 synthesis in human chondrocytes is regulated via the antagonistic actions of prostaglandin (PG)E2 and 15-deoxy-Δ(12,14)-PGJ2. 2011 PLoS ONE pmid:22096605
Alba G et al. Transcription of liver X receptor is down-regulated by 15-deoxy-Δ(12,14)-prostaglandin J(2) through oxidative stress in human neutrophils. 2012 PLoS ONE pmid:23115616
Isensee J et al. Subgroup-elimination transcriptomics identifies signaling proteins that define subclasses of TRPV1-positive neurons and a novel paracrine circuit. 2014 PLoS ONE pmid:25551770
Gonzalez-Rodriguez PJ et al. Dexamethasone protects neonatal hypoxic-ischemic brain injury via L-PGDS-dependent PGD2-DP1-pERK signaling pathway. 2014 PLoS ONE pmid:25474649
Paulitschke V et al. Proteome analysis identified the PPARγ ligand 15d-PGJ2 as a novel drug inhibiting melanoma progression and interfering with tumor-stroma interaction. 2012 PLoS ONE pmid:23049949
Yamamoto Y et al. Proteomic identification of protein targets for 15-deoxy-Δ(12,14)-prostaglandin J2 in neuronal plasma membrane. 2011 PLoS ONE pmid:21445266
Savinainen JR et al. Biochemical and pharmacological characterization of the human lymphocyte antigen B-associated transcript 5 (BAT5/ABHD16A). 2014 PLoS ONE pmid:25290914
Moon TC et al. Expression of DP2 (CRTh2), a prostaglandin Dâ‚‚ receptor, in human mast cells. 2014 PLoS ONE pmid:25268140
Yazid S et al. Anti-allergic cromones inhibit histamine and eicosanoid release from activated human and murine mast cells by releasing Annexin A1. 2013 PLoS ONE pmid:23527056
Samikkannu T et al. Immunopathogenesis of HIV infection in cocaine users: role of arachidonic acid. 2014 PLoS ONE pmid:25171226
Labrecque P et al. Inverse agonist and pharmacochaperone properties of MK-0524 on the prostanoid DP1 receptor. 2013 PLoS ONE pmid:23762421
Kanakasabai S et al. PPARγ agonists promote oligodendrocyte differentiation of neural stem cells by modulating stemness and differentiation genes. 2012 PLoS ONE pmid:23185633
Buckner MM et al. 15-Deoxy-Δ12,14-prostaglandin J2 inhibits macrophage colonization by Salmonella enterica serovar Typhimurium. 2013 PLoS ONE pmid:23922794
Liu L et al. Inhibition of oxidative stress-elicited AKT activation facilitates PPARγ agonist-mediated inhibition of stem cell character and tumor growth of liver cancer cells. 2013 PLoS ONE pmid:24023668
Sharvit E et al. Amplified inhibition of stellate cell activation pathways by PPAR-γ, RAR and RXR agonists. 2013 PLoS ONE pmid:24098526
Seno T et al. 15-Deoxy-Δ¹²,¹⁴ prostaglandin J₂ reduces the formation of atherosclerotic lesions in apolipoprotein E knockout mice. 2011 PLoS ONE pmid:22003398
de Jong E et al. Anticancer effects of 15d-prostaglandin-J2 in wild-type and doxorubicin-resistant ovarian cancer cells: novel actions on SIRT1 and HDAC. 2011 PLoS ONE pmid:21957481
Mechiche H et al. Prostanoid receptors involved in regulation of the beating rate of neonatal rat cardiomyocytes. 2012 PLoS ONE pmid:22984630
Weng Z et al. Quercetin is more effective than cromolyn in blocking human mast cell cytokine release and inhibits contact dermatitis and photosensitivity in humans. 2012 PLoS ONE pmid:22470478
Li H and Pauza CD Effects of 15-deoxy-delta12,14-prostaglandin J2 (15d-PGJ2) and rosiglitazone on human gammadelta2 T cells. 2009 PLoS ONE pmid:19888466
Cao DS et al. Expression of transient receptor potential ankyrin 1 (TRPA1) and its role in insulin release from rat pancreatic beta cells. 2012 PLoS ONE pmid:22701540
Khanim FL et al. Combined bezafibrate and medroxyprogesterone acetate: potential novel therapy for acute myeloid leukaemia. 2009 PLoS ONE pmid:19997560
Nagata N et al. Generation and characterization of an antagonistic monoclonal antibody against an extracellular domain of mouse DP2 (CRTH2/GPR44) receptors for prostaglandin D2. 2017 PLoS ONE pmid:28394950
Kida T et al. Prostaglandin D2 Attenuates Bleomycin-Induced Lung Inflammation and Pulmonary Fibrosis. 2016 PLoS ONE pmid:27992456
de Melo NF et al. 15d-PGJ2-Loaded Solid Lipid Nanoparticles: Physicochemical Characterization and Evaluation of Pharmacological Effects on Inflammation. 2016 PLoS ONE pmid:27575486
Philipose S et al. Laropiprant attenuates EP3 and TP prostanoid receptor-mediated thrombus formation. 2012 PLoS ONE pmid:22870195